Biophytis (BPTS) Peer Comparison
$7.03
$0.12
(1.74%)
As on 27-Jun-2024 09:30EDT
Market cap
$3 Mln
Revenue (TTM)
$-- Mln
P/E Ratio
--
P/B Ratio
2.3
Div. Yield
0 %
Edit
| Biophytis (BPTS) | Nanobiotix (NBTX) | Galapagos NV - ADR | Inventiva Sa (IVA) | DBV Technologies S.A. - ADR | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
3 | 2,213 | 1,862 | 1,106 | 914 |
Revenue (€ Mln) |
-- | 30 | 1,044 | 4 | -- |
Net Profit (€ Mln) |
-17.03 | -23.96 | 488.78 | -340.16 | -175.85 |
Net Margin (%) |
-- | -- | 46.83 | -540.52 | -- |
RoE (%) |
591.18 | 31.91 | 15.95 | 501.41 | -106.84 |
Price to Earnings |
-- | -- | 3.18 | -- | -- |
Price-To-Book |
2.26 | 65.02 | 0.49 | 2.10 | 5.59 |
Income Statement (€ Mln)
| Biophytis (BPTS) | Nanobiotix (NBTX) | Galapagos NV - ADR | Inventiva Sa (IVA) | DBV Technologies S.A. - ADR | |
|---|---|---|---|---|---|
|
Operating Revenue
|
0.00 | 36.21 | 239.72 | 17.48 | 15.73 |
|
Cost of Revenue
|
0.80 | -- | 35.99 | -0.02 | -4.50 |
|
Gross Profit
|
-0.80 | 36.21 | 239.72 | 17.50 | 15.73 |
|
Operating Expenses
|
15.09 | 62.99 | 327.99 | 120.19 | 92.16 |
|
Operating Profit (EBIT)
|
-15.89 | -26.78 | -88.26 | -102.71 | -76.43 |
|
Other Income
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
-18.59 | -39.58 | 5.63 | -109.82 | -72.72 |
|
Provision for Tax
|
-1.56 | 0.12 | 9.61 | 0.61 | 0.01 |
|
Profit after Tax (Net Income)
|
-17.03 | -39.70 | 211.70 | -110.43 | -72.73 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Consolidated Profit
|
-- | -- | -- | -- | -- |
Liabilities (€ Mln)
| Biophytis (BPTS) | Nanobiotix (NBTX) | Galapagos NV - ADR | Inventiva Sa (IVA) | DBV Technologies S.A. - ADR | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
-3.88 | -1.84 | 2,795.57 | -32.03 | 140.19 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Non-Current Liabilities
|
3.48 | 45.87 | 1,133.61 | 51.43 | 5.46 |
|
Current Liabilities
|
12.37 | 49.87 | 428.22 | 50.16 | 37.34 |
|
Total Liabilities
|
11.94 | 93.90 | 4,357.40 | 69.56 | 182.99 |
Assets (€ Mln)
| Biophytis (BPTS) | Nanobiotix (NBTX) | Galapagos NV - ADR | Inventiva Sa (IVA) | DBV Technologies S.A. - ADR | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
3.09 | 6.56 | 495.81 | 21.37 | 24.07 |
|
Current Assets
|
8.85 | 87.34 | 3,861.59 | 48.19 | 158.92 |
|
Total Assets
|
11.94 | 93.90 | 4,357.40 | 69.56 | 182.99 |
|
Total Debt*
|
8.27 | 50.57 | 9.60 | 37.49 | 6.55 |
|
Net Current Assets
|
-3.52 | 37.47 | 3,433.37 | -1.97 | 121.58 |
Cashflow (€ Mln)
| Biophytis (BPTS) | Nanobiotix (NBTX) | Galapagos NV - ADR | Inventiva Sa (IVA) | DBV Technologies S.A. - ADR | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-13.33 | -12.48 | -405.97 | -81.61 | -79.65 |
|
Cash Flow from Investing Activities
|
-- | -0.35 | 71.19 | -7.73 | -0.81 |
|
Cash from Financing Activities
|
7.49 | 46.77 | -5.00 | 29.08 | 6.77 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Biophytis (BPTS) | Nanobiotix (NBTX) | Galapagos NV - ADR | Inventiva Sa (IVA) | DBV Technologies S.A. - ADR | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-232.66 | -106.09 | 7.91 | -258.47 | -41.41 |
|
ROE (%)
|
591.18 | 274.85 | 7.96 | -1,642.76 | -43.47 |
|
ROA (%)
|
-100.38 | -51.67 | 4.66 | -119.02 | -33.87 |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
-- | -109.64 | 88.31 | -631.84 | -462.40 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| Biophytis (BPTS) | Nanobiotix (NBTX) | Galapagos NV - ADR | Inventiva Sa (IVA) | DBV Technologies S.A. - ADR | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-- | 6.58 | -0.01 | 0.44 | 2.25 |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
24.98 | 30.40 | 197.11 | -103.46 | 24.46 |
|
EPS Growth (%)
|
-- | 0.38 | 1.97 | -0.76 | 0.26 |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| Biophytis (BPTS) | Nanobiotix (NBTX) | Galapagos NV - ADR | Inventiva Sa (IVA) | DBV Technologies S.A. - ADR | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-- | -7.12 | 12.68 | -1.99 | -1.26 |
|
Price / Book Value
|
-- | -153.26 | 0.96 | -6.86 | 0.65 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
-0.15 | -10.89 | -19.43 | -2.26 | 0.47 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Biophytis (BPTS) | Nanobiotix (NBTX) | Galapagos NV - ADR | Inventiva Sa (IVA) | DBV Technologies S.A. - ADR | |
|---|---|---|---|---|---|
|
Debt to Equity
|
-2.13 | -27.42 | 0.00 | -1.17 | 0.05 |
|
Short term debt to equity ratio
|
-1.29 | -2.72 | 0.00 | -0.17 | 0.01 |
|
Current Ratio
|
0.72 | 1.75 | 9.02 | 0.96 | 4.26 |
|
Quick Ratio
|
-- | 1.75 | 8.84 | 0.95 | 4.27 |
|
Interest Coverage
|
-12.71 | -3.04 | 4.47 | -20.21 | -- |
Operating Efficiency Ratios
| Biophytis (BPTS) | Nanobiotix (NBTX) | Galapagos NV - ADR | Inventiva Sa (IVA) | DBV Technologies S.A. - ADR | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
-- | 8.19 | 27.39 | 89.87 | 98.20 |
|
Asset Turnover
|
0.00 | 0.47 | 0.05 | 0.19 | 0.07 |
|
Receivable days
|
-- | 29.30 | 108.94 | 167.04 | 309.39 |
|
Inventory Days
|
715.94 | -- | 643.97 | -6,272.77 | -90.94 |
|
Payable days
|
2,804.65 | -- | 1,359.71 | -452,894.12 | -1,534.06 |
|
Cash Conversion Cycle
|
-- | -- | -606.80 | 446,788.39 | 1,752.50 |
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
